Artificial intelligence for kidney cancer diagnosis

In a presentation at the 19th Meeting of the¬†European Association of Urology (EAU) Section of Oncological Urology the role of artificial intelligence in the diagnosis of kidney cancer was discussed. Artificial intelligence is the capability of a machine to learn in a similar manner to human beings through the use of data to determine an […]

read more

Artificial intelligence and immuno-oncology

The use of artificial intelligence (AI) in clinical practice using immunotherapy to treat cancer (immuno-oncology) is still in its infancy. However, AI has potential for overcoming some of the current challenges in immuno-oncology. Professor Thomas Powles, St Bartholomew’s Hospital, London, and Professor Pedro Romero, UNIL Ludwig Institute for Cancer Research, Lausanne, Switzerland discussed the promises […]

read more

Patients are willing to share personal data with the NHS, but not pharma

This blog starts with the results of a survey of 2000 people,¬†56% of which said they would be happy to share personal data with the NHS if it led to better services. But only 15% of those surveyed said they would be prepared to share personal data with pharmaceutical companies. The blog goes on to […]

read more

New artificial intelligence technique could help predict how cancer will mutate

New research, published in the journal Nature Methods, describes a new artificial intelligence (AI) technique that could help doctors predict how cancer tumours will mutate, and eventually allow them to personalise each individual’s treatment earlier. The research was conducted at The Institute of Cancer Research (ICR) in London, and has resulted in the development of […]

read more
Showing all 4 results